Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sigma HealthcareASX:SIG +0.34%58 5-Year Yield-on-Cost % is 1.13 as of Jul. 15, 2026, which is 66% below its 10-year median of 3.32. GuruFocus rates ASX:SIG with a GF Score™ of 58/100 and a GF Value™ of A$0.37 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 69 Medical Distribution companies, Sigma Healthcare ranks worse than 73.91% on this metric.
Sigma Healthcare's yield on cost for the quarter that ended in Dec. 2025 was 1.13.
The historical rank and industry rank for Sigma Healthcare's 5-Year Yield-on-Cost % or its related term are showing as below:
ASX:SIG'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.31 Med: 3.32 Max: 12.01
Current: 1.13
During the past 13 years, Sigma Healthcare's highest Yield on Cost was 12.01. The lowest was 0.31. And the median was 3.32.
ASX:SIG's 5-Year Yield-on-Cost % is ranked worse than 73.91% of 69
companies
in the Medical Distribution industry
Industry Median: 3.76
vs ASX:SIG: 1.13
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Sigma Healthcare 5-Year Yield-on-Cost % Related Terms
ASX:SIG vs MCK, CAH, COR: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, Sigma Healthcare's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sigma Healthcare 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Sigma Healthcare's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Sigma Healthcare (ASX:SIG) has a 5-Year Yield-on-Cost % of 1.13 as of Jul. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sigma Healthcare and its competitors. This is 66% below median its historical median of 3.32. Over the past decade, Sigma Healthcare's 5-Year Yield-on-Cost % has ranged from 0.31 to 12.01. According to the industry distribution chart, Sigma Healthcare ranks #51 out of 69 companies in the Medical Distribution industry, placing it in the top 73.9%.
Is Sigma Healthcare's 5-Year Yield-on-Cost % too high?
Sigma Healthcare's current 5-Year Yield-on-Cost % of 1.13 is 66% below median its 10-year median of 3.32. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 12.01. The Medical Distribution industry median 5-Year Yield-on-Cost % is 3.76. Sigma Healthcare's value of 1.13 is 69.9% below this industry median. Based on the distribution chart, Sigma Healthcare ranks #51 out of 69 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Sigma Healthcare has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's 5-Year Yield-on-Cost % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Sigma Healthcare ranks #51 out of 69 companies for 5-Year Yield-on-Cost %. This places Sigma Healthcare in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.76. Sigma Healthcare's value of 1.13 is 69.9% below this benchmark. Historically, Sigma Healthcare's own 5-Year Yield-on-Cost % has ranged from 0.31 to 12.01 over the past decade. While the company's 10-year median is 3.32 vs. the industry median of 3.76, Sigma Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.76, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sigma Healthcare's current 5-Year Yield-on-Cost % of 1.13 is 69.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sigma Healthcare and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sigma Healthcare's current 5-Year Yield-on-Cost % is 1.13, which is 66% below median its own 10-year median of 3.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sigma Healthcare (ASX:SIG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.37, compared to a current price of A$2.93 — trading 691.9% above its estimated fair value. The current 5-Year Yield-on-Cost % is 1.13, which is 66% below median its 10-year median of 3.32 and 69.9% below the Medical Distribution industry median of 3.76. Sigma Healthcare's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Sigma Healthcare (ASX:SIG), the current 5-Year Yield-on-Cost % is 1.13 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sigma Healthcare (ASX:SIG) Overvalued in 2026?
Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued.
The current stock price of A$2.93 is trading 691.9% above its estimated GF Value™ of A$0.37.
GuruFocus considers Sigma Healthcare to be Significantly Overvalued.
Key valuation signals for ASX:SIG:
5-Year Yield-on-Cost %: 1.13 (66% below median its 10-year median of 3.32)
GF Value™: A$0.37 vs. price of A$2.93 (691.9% above fair value)
Industry Position: 69.9% below the Medical Distribution median (#51 of 69)
No single metric tells the full story. See the ASX:SIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
58GF Score
Get the complete analysis for ASX:SIG
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:SIG has been successfully added to your 
